Literature DB >> 18324324

Reimbursement for new technologies: the GERD maze is not patient-friendly.

Steven D Schwaitzberg.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18324324      PMCID： PMC2258480     

Source DB:  PubMed          Journal:  Medscape J Med        ISSN： 1934-1997


× No keyword cloud information.
  5 in total

1.  Changing attitudes toward endolumenal therapy.

Authors:  J W Hazey; B J Dunkin; W S Melvin
Journal:  Surg Endosc       Date:  2007-03       Impact factor: 4.584

2.  Emerging endoluminal therapies for gastroesophageal reflux disease: adverse events.

Authors:  Atul K Madan; Craig A Ternovits; David S Tichansky
Journal:  Am J Surg       Date:  2006-07       Impact factor: 2.565

3.  Feasibility, safety, and efficacy of the Stretta procedure in Japanese patients with gastroesophageal reflux disease: first report from Asia.

Authors:  Kazuhide Higuchi; Yasuhiro Fujiwara; Hirotoshi Okazaki; Masahiko Tabuchi; Natsuhiko Kameda; Kaori Kadouchi; Hirohisa Machida; Tetsuya Tanigawa; Masatsugu Shiba; Toshio Watanabe; Kazunari Tominaga; Nobuhide Oshitani; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

4.  Improvement of objective GERD parameters after radiofrequency energy delivery: a European study.

Authors:  Peter N Meier; Tina Nietzschmann; Ibrahim Akin; Stefanie Klose; Michael P Manns
Journal:  Scand J Gastroenterol       Date:  2007-08       Impact factor: 2.423

Review 5.  Endoluminal GERD treatments: critical appraisal of current literature with evidence-based medicine instruments.

Authors:  Alfonso Torquati; William O Richards
Journal:  Surg Endosc       Date:  2007-03-31       Impact factor: 3.453
  5 in total
  2 in total

Review 1.  Novel challenges of multi-society investigator-initiated studies: a paradigm shift for technique and technology evaluation.

Authors:  Steven D Schwaitzberg; Robert H Hawes; David W Rattner; Michael L Kochman
Journal:  Surg Endosc       Date:  2013-06-11       Impact factor: 4.584

2.  A reader and author respond to "Reimbursement for new technologies: the GERD maze is not patient-friendly".

Authors:  John C Fekety
Journal:  Medscape J Med       Date:  2008-02-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.